Latest News Archive

Please select Category, Year, and then Month to display items

UFS HR Division bags Gold at 2024 IABC Gold Quill Awards

02 July 2024 | Story Lunga Luthuli | Photo Suplied

IABC Awards 2024 — The UFS HR Division celebrates its win at the 2024 IABC Gold Quill Awards for its 2023 UFS Women’s Breakfast.

The University of the Free State's (UFS’s) Human Resources Division has been awarded gold in the Special and Experiential Events Category at the 2024 International Association of Business Communicators (IABC) Gold Quill Awards held in Chicago, Illinois. This accolade recognises the division’s exceptional work on the 2023 UFS Women’s Breakfast, an event that exemplified innovative communication and organisational development.

"Winning the gold at the 2024 IABC Gold Quill Awards is a significant honour for both the Human Resources Division and the UFS," said Susan van Jaarsveld, Senior Director of the HR Division. "This recognition highlights our commitment to excellence and innovation in communication and organisational development. It validates the hard work and dedication of our team in fostering a positive workplace culture and enhancing employee engagement and well-being."

The 2023 UFS Women’s Breakfast was meticulously planned, and executed with a unique ‘journey’ theme. "Since we have just launched our onboarding programme based on a journey theme, we extended this theme to our Women’s Breakfast," van Jaarsveld explained. "A carefully curated communication strategy and plan guided our actions, and we invited guests to ‘board a flight’ with us, integrating the journey theme with our content. Our approach is neatly tied into the UFS’s Vision 130, which is a journey to a better destination."

The primary objectives of the event were to promote the UFS's Vision 130, and to increase participation in university initiatives. "Data collected after the event indicated that we did hit the mark," van Jaarsveld noted. "Guests felt more familiar with the UFS’s Vision 130, and also experienced a sense of inclusion. Participation in our initiatives increased significantly – in some cases by 200%. Our biggest problem this year is finding venues that can accommodate our growing numbers."

The success of the UFS Women’s Breakfast was attributed to several innovative elements, including a video invitation simulating an airport boarding call, and staff dressed as flight attendants. "Some attendees thought our team was hired from a professional airline – what a compliment to the UFS Organisational Development team!" van Jaarsveld remarked.

Van Jaarsveld emphasised the importance of such events for fostering community and engagement within the university. "Studies have shown that positive social events in the workplace improve employee engagement and satisfaction," she said. "It is important for employees to see and feel that they are valued, and that their well-being is a priority."

Looking ahead, the HR Division plans to continue creating impactful and award-winning events. "Teamwork makes dream-work! Our goal is to 'be better' – not just about achieving external recognition or awards, but about making a meaningful and lasting impact on the university community we serve," van Jaarsveld concluded.

The UFS Human Resources Division’s dedication, perseverance, and award-winning efforts demonstrate its innovative and engaging initiatives, setting a high standard for future events and reinforcing the university's commitment to excellence.

News Archive

Nuclear Medicine on the forefront of cancer research

2017-07-10

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma. The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

Back

Economic and Management Sciences

Education

Health Sciences

The Humanities

Law

Natural and Agricultural Sciences

Theology and Religion

Open Distance Learning

Business School

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept